Company Information

SANDU PHARMACEUTICALS LTD.

NSE : NABSE : 524703ISIN CODE : INE751D01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE64.001.5 (+2.4 %)
PREV CLOSE ( ) 62.50
OPEN PRICE ( ) 63.00
BID PRICE (QTY) 63.15 (23)
OFFER PRICE (QTY) 63.99 (5)
VOLUME 1226
TODAY'S LOW / HIGH ( )62.63 64.69
52 WK LOW / HIGH ( ) 4985
NSE
This Company is not listed in NSE
ChairmanBalram Viswanathan
Company SecretaryPratika Mhambray
Executive DirectorUmesh B Sandu
Non Executive DirectorShubhada P Sandu
Shashank B Sandu
Incorporation Year : 1985

Registered Office :

Address : Plot No 25, 26, 29 & 30,Pilerne Industrial Estate ,Marra Bardez,
Goa-403511 .

Phone : 0832-2407474 / 6715000

Email :  sandhupharma@sandu.in 

URL : www.sandu.in

Industry : Pharmaceuticals & Drugs

Listing : BSE,Ahmedabad

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.